SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Legend Biotech Says Multiple Abstracts Accepted for ASH 2026

The company said abstracts were accepted for the American Society of Hematology’s annual meeting, scheduled for December 12–15, 2026.

LEGN

Related stories